By using these reagents and v - abl - specific antisera, it was demonstrated that the P210 in CML cells is indeed the protein product of the 8.5 -
kilobase transcript.
Not exact matches
To test whether the P210 is the product of the novel 8.5 -
kilobase bcr / abl fusion
transcript, antibodies were prepared against c - abl and bcr determinants.
CML cells have two novel products: an 8.5 -
kilobase RNA
transcript containing both abl and bcr and a 210 - kilodalton phosphoprotein (P210) recognized by v - abl - specific antisera.